Vircon Legal advised Nanomik on its seed round led by TRAngels.
Nanomik is a Turkish nanotechnology and biotechnology company developing biological microbial solutions for agriculture — providing crop protection and soil-health products that reduce dependency on chemical inputs while increasing yield resilience. The company sits in the agri-biotech segment where the buyer is a structurally conservative industrial grower base, but the demand pressure from input-cost volatility, regulatory tightening on chemical actives and soil-degradation outcomes is now strong enough to materially shift adoption curves for credible biological alternatives.
Agri-biotech has emerged as one of the more strategically important deep-tech categories of the decade, supported by long-term capital allocators looking for durable, science-led businesses with measurable sustainability impact. Türkiye’s combination of a large agricultural base, strong academic research in microbiology and bioengineering, and access to MENA-region commercial markets makes it a credible launching geography for companies in this segment. Seed-stage rounds in deep-tech categories require investor networks that can support a multi-year R&D arc, scientific advisor recruiting and the regulatory pathway work that gates commercial deployment — rather than venture-style growth pressure.
TRAngels is Turkey’s most established angel investor network with hundreds of accredited members and a structured deal flow; the network specializes in early-stage technology investments across deep-tech, software and life sciences. For a deep-tech founder, the multi-member angel structure brings broad operator coverage across science, regulation and commercial domains that no single VC partner can typically match at the seed stage. The seed round positions Nanomik to extend its biological microbial product line and regulatory pathway work, with the kind of structured deep-tech angel backing the multi-year R&D arc in agri-biotech requires.
